RITALIN LA METHYLPHENIDATE 40MG 30CAPS

Attention deficit hyperactivity disorder (ADHD, DSM-IV): RITALIN® LA is indicated for the treatment of ADHD in children 6 years of age or older and in adults. Attention deficit hyperactivity disorder (ADHD), or ADHD (for its acronym in English: Attention Deficit / Hyperactivity Disorder), was previously known as or . Other terms used to describe this conduct disorder are: hyperkinetic syndrome, minimal brain injury, minimal brain dysfunction, minor brain dysfunction, and psychoorganic syndrome in patients. RITALIN® LA is indicated as part of a comprehensive program that includes psychological, pedagogical and social measures aimed at stabilizing patients who present with a conduct disorder syndrome characterized by moderate to severe distraction, short attention spans, hyperactivity, instability emotional, and impulsiveness. Diagnosis must be made according to DSM-IV criteria or ICD-10 guidelines. Neurological signs may be present (mild non-localized, learning disabilities and abnormal EEG); but it may also be that they do not appear, and the diagnosis of CNS dysfunction may or may not be necessary. Special considerations for the diagnosis of ADHD in children: The specific etiology of this syndrome is not known, and no diagnostic test is available. To diagnose it correctly it is necessary to carry out a multidisciplinary analysis that includes the medical, neuropsychological, pedagogical and social aspects. The most common characteristics of the disorder are: a history of short attention spans, distractibility, emotional instability, impulsivity, moderate or severe hyperactivity, mild neurological signs, and an abnormal EEG. In some cases, learning difficulties may occur. Diagnosis should be based on a complete history and evaluation of the child and not just on the presence of one or more of these features. Not all children with this syndrome need drug treatment. Stimulants are not indicated in children with symptoms induced by external factors (particularly abuse) and / or primary psychiatric disorders, including psychosis. It is essential to treat these cases in an adequate pedagogical environment, psychosocial intervention being generally necessary. When these measures are insufficient, the decision to prescribe a stimulant will depend on careful evaluation of the severity of the child's symptoms. Special considerations for diagnosing ADHD in adults: The specific cause of this syndrome is not known, nor is a single diagnostic test available. The characteristic symptomatology of ADHD in adults consists of constant changes in activity, prone to boredom, agitation, impatience and inattention. Symptoms such as hyperactivity tend to fade with age, possibly due to adaptation, neurodevelopment, and self-medication. Symptoms of inattention are predominant and have greater consequences in adults with ADHD. To make a correct diagnosis in adults, it is necessary to identify the patient's symptoms through a structured interview. It must be determined retrospectively if the patient has suffered from ADHD since childhood. The diagnosis should not be based exclusively on the presence of one or more symptoms. The decision to prescribe a stimulant in adults should only be made after a very thorough evaluation of the severity and chronic nature of the symptoms and their effects on the patient's daily life.